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Influenza A virus (IAV) is the etiological agent of a highly contagious acute respiratory disease that causes epidemics
and considerable mortality annually. Recently, we demonstrated, using an in vitro approach, that the pattern
recognition Toll-like receptor (TLR)3 plays a key role in the immune response of lung epithelial cells to IAV. In view of
these data and the fact that the functional role of TLR3 in vivo is still debated, we designed an investigation to better
understand the role of TLR3 in the mechanisms of IAV pathogenesis and host immune response using an experimental
murine model. The time-course of several dynamic parameters, including animal survival, respiratory suffering, viral
clearance, leukocyte recruitment into the airspaces and secretion of critical inflammatory mediators, was compared in
infected wild-type and TLR3
 / mice. First, we found that the pulmonary expression of TLR3 is constitutive and markedly
upregulated following influenza infection in control mice. Notably, when compared to wild-type mice, infected TLR3
 / 
animals displayed significantly reduced inflammatory mediators, including RANTES (regulated upon activation, normal
T cell expressed and secreted), interleukin-6, and interleukin-12p40/p70 as well as a lower number of CD8
þ T
lymphocytes in the bronchoalveolar airspace. More important, despite a higher viral production in the lungs, mice
deficient in TLR3 had an unexpected survival advantage. Hence, to our knowledge, our findings show for the first time
that TLR3-IAV interaction critically contributes to the debilitating effects of a detrimental host inflammatory response.
Citation: Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, et al. (2006) Detrimental contribution of the toll-like receptor (TLR)3 to influenza A virus-induced
acute pneumonia. PLoS Pathog 2(6): e53. DOI: 10.1371/journal.ppat.0020053
Introduction
Recent outbreaks of highly pathogenic inﬂuenza A virus
(IAV) infections have had important economic repercussions
and have raised concerns that a new inﬂuenza pandemic will
occur in the near future. The most severe complication of
inﬂuenza is acute pneumonia, which develops rapidly and
may result in respiratory failure and death. The etiological
agents of the disease, the single-stranded RNA inﬂuenza
viruses, are classiﬁed into three types (A, B, and C), of which
inﬂuenza A is clinically the most important [1]. In the United
States alone, there are more than 20,000 deaths per year, and
in the large pandemic of 1918, over 20 million people died
worldwide [2–4]. Although vaccines and antiviral molecules to
control inﬂuenza have been developed during the last years,
the disease is by no means under control since these
treatments are not available worldwide and their efﬁcacy is
not optimal [3–5]. Thus, a better understanding of the
molecular mechanisms of IAV pathogenesis and host immune
responses is required for the development of more efﬁcient
means of prevention and treatment of inﬂuenza.
The invasion of viruses is initially sensed by the host innate
immune system, triggering rapid antiviral responses that
involve the release of proinﬂammatory cytokines, and leading
to the subsequent activation of adaptive immune responses.
Diverse components of infecting viruses can induce the
signalling pathways that regulate the cellular antiviral gene
program. Among them, double-stranded RNA (dsRNA) has
beenviewedasthemostimportantcomponent.Itisacommon
signature linked to the viral replication cycle and lysis of virus-
infected cells is hypothesized to release dsRNA [6,7]. A major
transducer of cell signalling generated by dsRNA is the Toll-
likereceptor(TLR)3,amemberofaconservedfamilyofinnate
immune recognition receptors that have key roles in detecting
microbes, initiating innate immune responses, and linking
innate and adaptive immunity [8–10].
A role for TLR3 in viral detection has been suggested by in
vitro and ex vivo studies [8,11] but except for a recent study
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entry into the brain, causing lethal encephalitis, the func-
tional role of TLR3 in vivo remains unclear [12,13]. Recently,
using an in vitro approach, we demonstrated that TLR3 and
its signaling-associated molecule TRIF play a key role in the
immune response of respiratory epithelial cells to IAV [14]. In
the current study, we used TLR3-deﬁcient (TLR3
 / ) mice to
study the speciﬁc role of this pattern-recognition receptor in
IAV-mediated acute pneumonia. Our ﬁndings clearly indi-
cate that TLR3 contributes to a detrimental inﬂammatory
response.
Results
Kinetics of Pathological Features Associated with IAV
Infection
The pathogenesis and immune response associated with
inﬂuenza pneumonia are assumed to be very complex [15–
17]. To further dissect the role of TLR3 in IAV sensing and
pathogenesis, we ﬁrst characterized in infected wild-type
animals the time-course of major dynamic parameters,
including animal mortality and weight, leukocyte recruitment
into the airspaces, increase in alveolocapillar permeability,
and secretion of critical mediators. Figure 1A shows that all
C57Bl/6 mice inoculated intranasally with IAV at a dose of
300 plaque-forming units (pfu) per mouse died within 12 d.
Signs of piloerection and anorexia were associated with a loss
of weight (approximately 32%) and appeared after 4 d of
infection (Figure 1B). Animals were killed at different
intervals postinfection, and bronchoalveolar lavage (BAL)
samples were collected to assess cellular inﬁltration and
mediators content in the airspaces. Figure 1C (square symbol)
shows a biphasic leukocyte recruitment constituted mainly of
polymorphonuclear cells (circle symbol) by days 3 to 8
Figure 1. Time-course of Dynamic Parameters in Wild-Type Mice Infected by a Lethal IAV Challenge
Male C57Bl/6 mice were infected intranasally with 300 pfu of IAV and different parameters were analyzed during the course of infection.
(A) Survival of mice.
(B) Body weight changes.
(C) Leukocyte recruitment into the airways (&, all leukocytes; , polymorphonuclear cells; m, mononuclear cells).
(D and E) RANTES and IL-6 production in BAL fluids.
(F) Total protein amount in BAL fluids as an index of alveolocapillar permeability. All these results are the mean 6 SD values obtained from three
distinct animals and are representative of three independent experiments.
DOI: 10.1371/journal.ppat.0020053.g001
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Synopsis
Influenza A virus (IAV) is responsible for highly contagious acute
respiratory disease. Recent concerns have risen concerning a
possible influenza pandemic in the near future. Thus, a better
understanding of the molecular mechanisms of IAV pathogenesis
and host immune responses is required for the development of
more efficient means of prevention and treatment of influenza. The
Toll-like receptor (TLR)3 is a member of a family of receptors that
detects microbes and triggers host defenses. We previously
demonstrated using an in vitro approach, that the TLR3 plays a
key role in the response of lung epithelial cells to IAV. Here, we used
a mouse model to dissect the in vivo importance of TLR3-dependent
responses during influenza. The time-course of several parameters,
including animal survival, respiratory distress, viral clearance, and
inflammation, was compared in infected control wild-type and TLR3-
deficient mice. Our findings reveal that TLR3
 /  mice have an
unexpected advantage against IAV challenge as we show for the
first time that a reduction of TLR3-mediated inflammatory response
reduces the clinical manifestations of IAV-induced pneumonia.postinfection and of mononuclear cells (triangle symbol)
afterward. The kinetics of IAV-induced secretion of a major
cytokine (IL-6) and a CC chemokine (RANTES) was inves-
tigated. While RANTES peaked at day 3 and decreased
signiﬁcantly thereafter (Figure 1D), IL-6 secretion increased
steadily until day 4 and was sustained at that level until day 11
(Figure 1E). As an index of transudation from the vascular
compartment into the lungs, the amount of total protein was
determined in the BAL (Figure 1F). Interestingly, the protein
concentration curve parallels that of total leukocyte content
(Figure 1C, square symbol) conﬁrming a connection between
increased microvascular permeability and cellular inﬁltration
during acute lung injury [18]. BAL ﬂuids were further
analyzed by an inﬂammatory protein array to examine at
days 3 and 10 postinfection whether other major compo-
nents, not measured in the initial assays, were affected during
inﬂuenza pneumonia. A total of 32 mediators were measured,
which included 16 cytokines, 11 chemokines, three growth
factors, one metalloproteinase inhibitor, and one soluble
cytokine receptor (an example of such protein array blot is
shown later in Figure 4A) This array analysis indicated
selective major increases of granulocyte colony-stimulating
factor (G-CSF), IL-6, monocyte chemoattractant protein-1
(MCP-1), MCP-5, macrophage inﬂammatory protein-2a,
RANTES, soluble tumor necrosis factor-a (TNFa) receptor,
and tissue inhibitor of metalloproteinase-1 (not illustrated).
Next, we checked that the lethal pneumonia induced by IAV
was not associated with a bacteria superinfection, as it has
been reported by others [19]. We showed that bacteria counts
in blood or BAL of IAV-treated mice at day 3, 6, 8, or 10
postinfection were negligible (constantly below 250 cfu/ml).
In addition, intramuscular administration of the mice with a
large-spectrum antibiotic (Clamoxyl; amoxicillin trihydrate-
potassium clavulanate, 25 mg/kg) before and during the viral
infection did not reduce or delay the survival pattern
(unpublished data).
IAV Upregulates the Lung Expression of TLR3
We previously demonstrated that of all the mediators we
tested, i.e., bacterial LPS, the cytokines TNFa and IL-1b, the
protein kinase C activator PMA, IAV, and the synthetic dsRNA
poly(I:C), only the two latter stimuli upregulated TLR3
expression in human pulmonary epithelial cells, suggesting
that the signaling pathways controlling the induction of this
gene are restricted [14]. Given the distinct complexity
between in vitro and in vivo systems, there was a need to
determine the regulation and the function of TLR3 in relation
to the pathogenesis of inﬂuenza in an experimental animal
Figure 2. Reduced Lethality in IAV-Infected TLR3
 /  Mice
(A) Pulmonary expression and regulation of TLR3 during influenza infection. Mice were either noninfected (Ctrl) or infected with 300 pfu of IAV by
intranasal route and whole lungs were harvested at 2, 3, 4, and 9 d postinfection. Total RNA was extracted and TLR3 mRNA was analyzed by RT-PCR; a
representative result of two is shown. b-Actin mRNA was assessed as a control for RNA loading.
(B) Lethality induced by IAV in TLR3
 / and MyD88
 / mice in comparison with wild-type mice. Age-matched TLR3
 / , MyD88
 / , and wild-type male mice
received intranasally 300, 100, or 30 pfu of IAV. Wilcoxon test for comparisons of Kaplan-Meier survival curves indicated a significant increase in the
survival of TLR3
 /  mice compared to that of wild-type animals (****p , 0.0001, *p , 0.05) but not to that of MyD88
 /  mice.
DOI: 10.1371/journal.ppat.0020053.g002
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the lungs of infected mice is constitutive and markedly
upregulated following IAV administration, peaking at day 3
and slightly decreasing at day 9 postinfection (Figure 2A).
Reduced Inflammation and Lethality in IAV-Infected
TLR3
 /  Mice
Remarkably, we showed that TLR3
 /  mice had a more
prolonged survival after a challenge of 300 pfu IAV than did
wild-type animals as determined by a Kaplan-Meier test; i.e.,
approximately 26% and 0% survival, respectively, at day 12
postinfection (n ¼ 35 and 65, respectively; p , 0.0001, Figure
2B, left upper panel). Ultimately, all TLR3
 /  mice died 3 to 5
d later. We have also performed survival experiments that
were conducted with lower doses of virus (100 and 30 pfu;
Figure 2B, lower panels). The results clearly show that the
absence of TLR3 can undeniably protect the mice from the
lethal viral effects. Thus, after a challenge of 100 pfu IAV,
TLR3
 /  mice have an even more enhanced survival (approx-
imately 60%; even after a month postinfection; n ¼ 5)
compared to wild-type animals (0%, n ¼ 13). Infection with
30 pfu IAV affected neither the wild-type nor the TLR3
 / 
mice (n ¼ 5). Interestingly, mice deﬁcient for the adapter
protein myeloid differentiation (MyD)88, which is involved in
the signaling of all TLR molecules but TLR3, were as sensitive
as wild-type mice to inﬂuenza infection (0% survival for both
groups, Figure 2B, right upper panel; n¼8). Then, to monitor
the role of TLR3 in lung dysfunction induced by the viral
infection, the respiratory distress index Penh and total
protein amount as well as the secretion of inﬂammatory
cytokines and chemokines were evaluated in BAL ﬂuids of
TLR3
 /  and wild-type animals at day 3 postinfection by 300
pfu IAV (this time point was chosen as it corresponds to the
peak of the viral load in the lungs of both animal groups, cf.
Figure 5). Figure 3A shows that the Penh index was
signiﬁcantly diminished in TLR3
 / mice compared to control
mice, i.e., 0.95 6 0.12 versus 1.74 6 0.2, respectively (n¼5, p¼
0.005). Likewise, total protein, RANTES, and IL-6 amounts
were signiﬁcantly lower in TLR3
 /  than in wild-type mice
(Figure 3B–3D). BAL ﬂuids were further analyzed by an
inﬂammatory protein array to examine at day 9 whether the
expression of additional mediators was directly regulated by
TLR3. Figure 4A not only conﬁrms a clearly reduced IL-6
production in the lungs of TLR3
 /  mice but also reveals a
similar inhibition concerning inﬂammatory mediators such
as IL-12p40/p70, sTNFR1, and tissue inhibitor of metal-
loproteinase-1. On the contrary, the expression of distinct
components is increased in TLR3
 /  versus wild-type lungs,
including not only INF-c but also G-CSF and, to a lesser
extent, IL-9 and IL-10. As additional evidence, we showed by
ELISA that, although similar at day 4 to day 7 post–viral
infection, the amount of interferon (IFN)-c in TLR3
 /  mice
was greater (approximately 14.5 times that of wild-type
animals) at day 9 (Figure 4B). Finally, Figure 4C presents a
typical gross morphological view of perfused lungs isolated
from noninfected wild-type and TLR3
 /  mice (lower panel)
and at day 9 postinfection by 300 pfu of IAV (upper panel).
Lungs of wild-type animals appeared severely injured as
manifested by an almost black hemorrhaged lung surface,
whereas those obtained from TLR3
 /  mice produced only
faintly and diffuse red lungs, suggesting that the lesions
induced by IAV are reduced in the absence of TLR3.
Paradoxical Increased Lung Viral Load in TLR3
 /  Mice
The previous results indicated that a potent inﬂammatory
reaction occurs in the lungs of wild-type mice after inﬂuenza
infection and that this process is critically reduced or altered
in TLR3
 /  animals.
Inﬂammatorysignalingpathwaysduringviralinfectionhave
been interpreted in some cases as a protective response of the
host,whereasinothercasestheviruscanutilizethesepathways
to enhance its replication [20]. Thus, we ﬁrst used quantitative
RT-PCR (qRT-PCR) to investigate whether TLR3-dependent
host response might regulate the replication of IAV. Figure 5
shows that virus replication was major in both wild-type and
TLR3
 / mice with very similar titers when examined on days 1
to 4 post–viral infection. Paradoxically, while control animals
had signiﬁcantly reduced the virus load of their lungs at day 9
postinfection, the virus persisted in TLR3
 /  mice with an
elevated amount (approximately nine times that of wild-type
animals). Note that we also used a more traditional method to
accurately determine IAV potency. Viral replication was
studied in MDCK cell lines at day 9 postinfection, according
to a standard protocol [21]. We conﬁrmed that TLR3
 /  mice
hada signiﬁcantly higherIAVamountintheirlungs compared
to wild-type animals (p , 0.001).
Wild-Type and TLR3
 /  Mice Raise a Contrasted Leukocyte
Content in Their Lungs after Infection by IAV
Some of the foregoing ﬁndings suggested that a TLR3-
mediated host immune response plays a harmful role in the
Figure 3. Reduced Inflammation in IAV-Infected TLR3
 /  Mice
(A) Basal respiratory function of wild-type versus TLR3
 /  mice before
(day 0) and 3 d post–viral infection. This was measured using a
barometric plethysmographic chamber and is expressed as Penh (cf.
Materials and Methods for details), the increase of which is an indicator
of deterioration changes in airway mechanics (**p , 0.01).
(B–D) BAL fluids levels of total protein, RANTES, and IL-6 in wild-type
versus TLR3
 / mice before (day 0) and 3 d post–viral infection (*p , 0.05,
***p , 0.001, ****p , 0.0001). Histograms are the mean 6 SD values
obtained from five animals and are representative of at least three
independent experiments.
DOI: 10.1371/journal.ppat.0020053.g003
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several studies revealed a functional redundancy and synergy
of different immune cells in the antiviral response to IAV
[15,17,22]. Thus, to gain insight into which cell type can
possibly participate in the TLR3-regulated detrimental
immune response, leukocytes were harvested from the BAL
of wild-type and TLR3
 /  mice 9 d postinfection and the
number and phenotype of the cells were characterized by
ﬂow cytometry. Infection of wild-type mice with IAV resulted
in a signiﬁcant increase in the number of leukocytes (cf.
Figure 1C), and the accumulated cells in the BAL were
composed mostly of T-lymphocytes (55 3 10
4 6 12.5 3 10
4/
BAL), neutrophils (23 3 10
4 6 4.1 3 10
4/BAL), and macro-
phages (11 3 10
4 6 2.2 3 10
4/BAL) (Figure 6, left and central
panels); these numbers have to be compared to a leukocyte
population in naı ¨ve mice constituted by approximately 90%
macrophages (Figure 6, left panels and [23]). The absolute
numbers of the whole leukocyte population in the BALs from
either infected wild-type or TLR3
 /  mice were similar
(approximately 1 3 10
6 cells). Among the T lymphocytes,
the CD8
þ T cells were the predominant cell population in the
lungs of infected wild-type animals (37.3 3 10
4 6 7.8 3 10
4/
Figure 4. Distinct Inflammatory Profile in Wild-Type and TLR3
 /  Mice Infected by a Lethal IAV Challenge
(A) BAL fluids levels of inflammatory mediators at day 9 postinfection. The data were normalized to internal positive controls spotted on the same
protein array membrane and are expressed as relative units. (Inset) Example of a protein array blot probed with BAL collected from wild-type and TLR3
 / 
mice. Relevant spots are highlighted: (1) G-CSF, (2) IL-12p40/p70, (3) IFN-c, and (4) RANTES.
(B) BAL fluids levels of IFN-c in wild-type (&) and TLR3
 / (&) mice before (day 0) and 4, 7, and 9 d postinfection by 300 pfu IAV (*p , 0.05). Histograms
are the mean 6 SD values obtained from five animals and are representative of three independent experiments.
(C) Examination of lungs isolated from noninfected wild-type and TLR3
 /  mice (lower panel) and at day 9 post–viral infection (upper panel).
DOI: 10.1371/journal.ppat.0020053.g004
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þ, but not CD4
þ,T
lymphocytes in TLR3
 /  mice was considerably lower (about a
third of that found in wild-type animals (i.e., 14.5310
4 6 4.5
3 10
4/BAL; p ¼ 1 3 10
 6; Figure 6, right and central panels).
Likewise, a signiﬁcant reduction (approximately 1.5 times) of
the number of macrophages was observed in TLR3
 /  mice
(i.e., 7.6 3 10
4 6 0.99 3 10
4/BAL; p ¼ 0.004), whereas the
number of neutrophils was 1.5 times higher in this same
group of mice (i.e., 32.9 3 10
4 6 4.9 3 10
4/BAL, p ¼ 0.0009;
Figure 6, right and central panels).
Discussion
Our understanding of how the immune system recognizes
pathogens has increased exponentially in recent years due to
the discovery of the TLR family. TLRs play a central role in
the detection of pathogen-associated molecular patterns and
in the initiation of an effective innate and adaptive immune
response [9,10]. In agreement with this paradigm, there is
accumulating in vivo evidence using TLR
 / mice that support
a role for these receptors in antibacterial, antifungal, and
antiviral defense. Moreover, several clinical reports conﬁrm
the contribution of TLRs to the pathophysiology of infectious
diseases, and polymorphisms in TLR genes are associated
with predisposition to severe infections [24].
In view of this major information, we anticipated at the
start of our investigation that TLR3 would act as a protective
component and, conversely, its absence in TLR3
 /  mice
would render the animals more susceptible to IAV infection.
On the contrary, our study reveals that mice deﬁcient in
TLR3 have an unexpected advantage. Thus, in comparison
with wild-type mice, we found in TLR3
 /  animals (i) a clearly
reduced level of inﬂammatory mediators in the bronchoal-
veolar spaces, including RANTES, IL-6, and IL-12p40/p70; (ii)
a lower number of the predominant leukocyte population in
the airspaces, i.e., the CD8
þT cells; and, most important, (iii) a
paradoxical longer survival. Based on these ﬁndings and in
view of previous work describing the major role of CD8
þ T
lymphocytes and cytokines in the pathogenesis of inﬂuenza
infection, we discuss below the fact that the enhanced
resistance of IAV-infected TLR3
 /  might be due to a lower
TLR3-mediated release of inﬂammatory mediators and T cell
inﬁltration in the lung airspaces.
It is established that IAV replicates in epithelial cells and
leukocytes, resulting in the production of chemokines and
cytokines that favors the recruitment of mononuclear cell
population to the site of infection. There is growing evidence
that the mediators that have a central role in the resolution of
inﬂuenza are the same that can be the cause of many clinical
signs related to this pathology [25–27]. We conﬁrm in the
present study that inﬂuenza infection leads to the synthesis of
major inﬂammatory cytokines and chemokines, including IL-
6, G-CSF, IL-12p40/p70, MCPs, macrophage inﬂammatory
proteins, and RANTES. Remarkably, IL-6 exhibits multifunc-
tional activities that are largely proinﬂammatory and its
release has been correlated with the symptom pathogenesis
during acute inﬂuenza [26]. IL-12 administration was also
found to have an adverse effect on the course of inﬂuenza
infection [27]. Other studies reported the involvement of
cytokines in inﬂuenza pathogenesis, but the blockade of one
individual cytokine appears somewhat partial as there is a
substantial redundancy between cytokines [15,17]. Notably,
our study clearly establishes that TLR3 plays a major role in
the inﬂammatory cytokine response to IAV, the lack of TLR3
resulting in a signiﬁcant decrease of cytokine synthesis,
including that of IL-6, IL-12p40/p70, and RANTES. Ongoing
loss-of-function in vitro studies with human pulmonary
epithelial cells also demonstrate an essential function for
TLR3 in the production of inﬂammatory cytokines, including
IL-6, after IAV challenge (unpublished data). On the contrary,
the expression of some other mediators is increased in
TLR3
 /  versus wild-type lungs. The consequences and the
mechanisms of this TLR3-regulated differential expression of
cytokines and chemokines are rather complex to hypothesize
at this stage due to the pleiotropic and multiple effects of
these mediators on diverse cell types. Moreover, these
molecules induce or inhibit the production of other cytokines
or mediators from their targets in a complex array of positive
and negative feedback loops [15,17].
Regardless, consistent with the role of TLR3 in virus-
induced inﬂammation, two of us recently established that
infection of TLR3
 /  mice with the West Nile virus induces a
lower secretion of cytokines, including IL-6 and TNF-a,
compared to wild-type mice, that leads to reduced neuronal
injury and increased survival in TLR3
 /  mice [13]. Similarly,
in a study examining the role of another TLR in the host
response to herpes simplex virus, Kurt-Jones et al. [28]
demonstrated an attenuated cytokine response parallel to a
reduction in symptoms of encephalitis in TLR2
 /  compared
to control animals. It is of note, however, that our results still
demonstrate high mortality when the TLR3
 /  strain was
infected by a high viral amount of IAV, although the
difference between this group and wild-type animals is highly
signiﬁcant (p , 0.0001). This ﬁnding suggests that TLR3
contributes to the shaping of a harmful innate and adaptive
immune response at an extent that varies under the IAV load,
i.e., that supplementary signaling pathways may be involved
at high viral load. In that regard, it is of note that while TLR3
has emerged as a key sensor of viral dsRNA, very recent
studies show that cells also express RNA helicases that
Figure 5. Viral Load in the Lungs of IAV-Infected Mice
Viral load in TLR3
 /  and wild-type mice challenged intranasally by 300
pfu of IAV.
(A) Results are the mean 6 SD values obtained from four animals at days
2 to 4 postinfection and 17 mice at day 9 postinfection. They are
expressed as RNA copies normalized to b-actin expression levels, as
determined by real-time PCR.
(B) Results are the mean 6 SD values obtained from nine wild-type and
eight TLR3
 /  mice at day 9 postinfection. They are expressed as pfu, as
determined by standard plaque assay [21].
DOI: 10.1371/journal.ppat.0020053.g005
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detect actively replicating viruses in cytoplasm (reviewed in
[29]). Hence, depending on the IAV dose, it is tempting to
speculate that the activity of one dsRNA receptor or the other
may be transiently switched on or off. The in vivo evidence
that RNA helicases–IAV interaction contributes to the
debilitating effects of a detrimental inﬂammation awaits
further studies.
Figure 6. Wild-Type and TLR3
 /  Mice Raise a Contrasted Leukocyte Content in Their Lungs after IAV Challenge
BAL cells were collected from IAV-infected mice at day 9 postinfection. To characterize the recovered leukocyte cell types, polymorphonuclear
neutrophils (PMN, Gr1
þ, CD11b
þ), macrophages (Mu, F4/80
þ), CD4
þ T lymphocytes (CD4), and CD8
þ T lymphocytes (CD8) were stained with
fluorescently labeled specific antibodies. Far right and far left dot-plots: Representative BAL cell composition of naive wild-type and TLR3
 / mice. Right
and left dot-plots: Representative BAL cell composition of wild-type mice and TLR3
 / mice at day 9 postinfection by 300 pfu of IAV. Central histograms:
Results are the mean 6 SD obtained from 12 wild-type mice and seven TLR3
 /  mice (**p , 0.01, ***p , 0.001, ****p , 0.0001).
DOI: 10.1371/journal.ppat.0020053.g006
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subsequent adaptive T cell responses. This is the case for
IFN-c, which is generally considered as essential for the
control of many microbial infections, and its important role
in the antiviral immune defense is highlighted by the fact that
several viruses encode proteins designed to interfere with
IFN-c signaling [30]. However, most current evidence studies
suggest that it may also exert a strong negative effect on the
CD8
þ T cell, a critical cellular component of the adaptive
immune response. Thus, T cells treated with IFN-c show
reduced proliferation and/or increased apoptosis [31]. More-
over, IFN-c can act as a negative feedback regulator to control
Th1-mediated immune responses [32]. In view of those data, it
may be conceivable that the excessive IFN-c recovered from
the airspaces of TLR3
 /  mice might contribute to a decrease
in CD8
þ T cell number and to a limitation of T cell–mediated
inﬂammation in this group of animals, in comparison with
wild-type mice. Indeed, although the recruitment of CD8
þ T
cells is essential for protective responses, it is becoming
increasingly evident that they can also be associated with the
development of inﬂuenza-related immunopathological se-
quelae [33,34]. We conﬁrmed that CD8
þT cells are prominent
in the airways of IAV-challenged wild-type mice. The drastic
decrease in CD8
þ T lymphocyte inﬁltration concomitant with
the prolonged survival of the TLR3
 /  mice suggests that a
dysregulated TLR3-dependent CD8
þT cell response may lead
to sustained lung injury. Accordingly, this idea sheds new light
on previous studies that have reported that mice given
antilymphocyte serum [35] or the immunosuppressive drug
cyclophosphamide had a lesser pulmonary pathology when
infected with IAV than untreated mice [36,37]. Moreover,
numerous studies reported that athymic nude mice exhibited
an increased survival time compared to immunocompetent
mice given inﬂuenza challenge [38–40]. Other authors have
more speciﬁcally suggested that CD8
þ T lymphocytes exacer-
bate the inﬂuenza pathology and cause mortality at high viral
infection [41]. Clinical observations also lend support to the
fact that CD8
þ T lymphocytes may contribute to the
pathological manifestations of IAV infection [42]. Of note is
that the detrimental role of the cell-mediated immune
response during inﬂuenza is analogous to infection with the
prototypic arenavirus lymphocytic choriomeningitis virus.
Indeed, immunodepressed mice infected with this virus do
not die as do immunocompetent mice, despite persistent viral
production [43]. This latter feature is especially meaningful in
regard to the inability of TLR3
 /  mice as well as athymic
animals [38–40] to clear the IAV, whereas they live longer than
control animals.
Overall, it emerges that the etiology and pathogenesis of a
very complex disease such as inﬂuenza likely involve a
combination of both virus effects per se and the imbalance
between the beneﬁcial and harmful effects of mediators
released by immune cells. Moreover, a clear conclusion from
our work is that a reduction in TLR3-mediated inﬂammatory
inﬁltrate reduces the clinical manifestations of IAV-induced
pneumonia. Nonetheless, although potentially valuable, there
would be no overall beneﬁt from treating inﬂuenza solely
with TLR3 downregulators as we found that the lack of TLR3
resulted in increased pulmonary IAV load. Hence, while
vaccination should remain the basis for inﬂuenza prophylaxis
[44], we suggest that along with inhibitors of viral replication,
a concomitant treatment with modulators of TLR3 might be
useful in the management of IAV infections, particularly in
at-risk groups during periods when there is a mismatch
between the epidemic strain and the vaccine strain.
Materials and Methods
Virus preparation and quantiﬁcation. Inﬂuenza A/Scotland/20/74
(H3N2) virus was generously provided by N. Escriou and S. Van Der
Werf(Unite ´d eG e ´ne ´tiqueMole ´culairedesVirusRespiratoires,Institut
Pasteur, Paris, France). The virus was prepared as previously described
[14]. Viral RNA was isolated from the viral stock with an RNeasy mini-
kit (Qiagen, Hilden, Germany) and quantiﬁed with a Nanodrop ND-
1000 spectrophotometer (Rockland, Delaware, United States). cDNA
derived from the viral RNA sample was used as a standard for a qRT-
PCR. qRT-PCR was then performed using speciﬁc primers (sense: 59
AAGACCAAT CCT GTC ACCTCT GA 39 and antisense: 59 CAAAGC
GTC TAC GCT GCA GTC C 39; Proligo, Evry, France) that comple-
ment 20 temporally and spatially divergent inﬂuenza A matrix protein
gene sequences, as previously described [45].
Mouse strains. Males C57Bl/6 mice were purchased from the
Centre d’Elevage R. Janvier (Le Genest Saint-Isle, France) and were
used at about 8 wk of age. MyD88
 / and TLR3
 / mice were generated
as described earlier [8,46]. MyD88
 /  mice were obtained from Dr. S.
Akira (Osaka University, Osaka, Japan). Each type of mice was
backcrossed at least eight times with C57Bl/6 to ensure similar genetic
backgrounds. Mice strains were bred in an animal facility in
pathogen-free conditions. Mice were fed normal mouse chow and
water ad libitum and were reared and housed under standard
conditions with air ﬁltration. For experiments of infection by IAV,
mice were housed in cages inside stainless steel isolation cabinets that
were ventilated under negative pressure with HEPA-ﬁltered air. Mice
were treated in accordance with Pasteur Institute guidelines in
compliance with the European animal welfare regulation.
Animal ﬂuid collection. Mice were anesthetized by a mixture of
ketamine-xylazine (1 and 0.2 mg per mouse, respectively) and
infected intranasally with 50 ll of PBS containing 300, 100, or 30
pfu IAV. Mice were observed daily for signs of morbidity.
Alternatively, mice were killed at different time points by intra-
peritoneal injection of 300 mg/kg sodium pentobarbital, and 1 ml of
heparinized blood was collected by the vena cava. After centrifuga-
tion at 300g, the resulting plasma was stored. Airways were washed
twice with 1 ml of saline, and the BAL was collected to further
determine cell differential counts and percentages using a Coulter
counter (Coulter-Electronics, Margency, France) as well as a Diff-
Quik staining (Baxter-Dale, Dudingen, Germany) of cytospin slides.
Aliquots of BAL ﬂuids were stored for total protein and cytokine
measurement. For ﬂow cytometry analysis, cells were eventually
counted and stabilized with Cyto-Chex (Sireck, Omaha, Nebraska,
United States). Under these conditions, cells could be stored for 1 wk
at 4 8C before labeling for ﬂow cytometry analysis.
Monoclonal antibodies for ﬂow cytometry analysis. MAbs reactive
to CD11b (Mac-1, M1/70, rat IgG2a), Ly-6G-Gr1 (clone RB6-8C5, rat
IgG2b), CD8 (clone 53–6.7, rat IgG2a), and CD4 (clone RM4–5, rat
IgG2a) were purchased from BD PharMingen (San Diego, California,
United States) as conjugated to ﬂuorescein isothiocyanate, phycoer-
ythrin, or cy-Chrome. Phycoerythrin-conjugated F4/80 (clone C1:A3–
4, rat IgG-2b) was purchased from Caltag Laboratories, Burlingame,
California, United States. Before ﬂow cytometry analysis, cells were
washed in PBS containing 5% FCS and stained for 30 min at 4 8C with
the conjugated Abs. Cells were further washed twice and analyzed on
a FACScan ﬂow cytometer (BD PharMingen).
RANTES, IL-6, and IFN-c ELISA. Murine RANTES, IL-6, and IFN-c
concentrations in BAL were determined using DuoSet ELISA kits
obtained from R&D Systems (Minneapolis, Minnesota, United States).
Inﬂammatory protein array. A commercial antibody-based protein
array designed to detect 32 inﬂammatory mediators was used
according to the manufacturer’s instructions (RayBio Mouse Cyto-
kine Array II; RayBiotech, Atlanta, Georgia, United States). Mem-
brane arrays were hybridised with BAL ﬂuids to compare different
types of mice and different time points and were always processed
simultaneously. Array images were recorded after ampliﬁcation with
an Ultra-Lum system (Ultra-Lum, Claremont, California, United
States), and all scanned images accurately reproduced spots seen on
ﬁlms.
RT-PCR. RNA was extracted from the lung tissue using the
FastRNA GREEN Kit and FastPrep instrument (Bio 101, Qbiogene,
California, United States) according to the protocol from the
manufacturer. RNA was reverse transcribed using 0.5 lg of total
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TLR3 and Influenza Virus InfectionRNA. PCR was performed using speciﬁc primers (Proligo, Evry,
France) for mouse TLR3 (sense: 59 GCT CAT TCT CCC TTG CTC AC
39; antisense: 59 CCC GAA AAC ATC CTT CTC AA 39). As an internal
control, we used primers for mouse b-actin (sense: 59 GGA CTC CTA
TGT GGG TGA CGA GG 39; antisense 59 GGG AGA GCA TAG CCC
TCG TAG AT 39). Ampliﬁcations were performed in a Peltier thermal
cycler apparatus (MJ Research, Watertown, Massachusetts, United
States) using the Qbiotaq polymerase (Qbiogene, Illkirch, France). To
detect mTLR3, the thermocycling protocol was 95 8C for 3 min, 35
cycles of denaturation at 95 8C for 30 s, annealing at 58 8C for 30 s,
and extension at 72 8C for 1 min. To detect b-actin, only 30 cycles
were used and the annealing temperature was 62 8C. Ampliﬁcation
products were resolved on 1.5% agarose gel containing ethidium
bromide. Band intensities on gels were recorded after ampliﬁcation
with an Ultra-Lum system. Samples for each point were serially
diluted to verify that PCR was performed in the linear phase of the
ampliﬁcation reaction (unpublished data).
Assessment of the basal respiratory function. Unrestrained
conscious mice, infected or not by IAV, were placed in a whole body
plethysmographic chamber (Buxco Electronics, Sharon, Connecticut,
United States) to analyze the respiratory waveforms. The system
measures both the magnitude and the slope of the chamber pressure.
After a 10-min stabilization period, the basal respiratory capacity of
each individual mouse was estimated by recording the enhanced
pause pressure expressed as ‘‘Penh,’’ calculated as Penh ¼ [Te
(expiratory time)/Tr (relaxation time)]   1 3 [Pef (peak expiratory
ﬂow)/Pif (peak inspiratory ﬂow)]. The values of Penh expressed per
minute were averaged from three determinations recorded every 20 s.
A Penh increase is an indicator of deterioration in airway mechanics.
Statistical analysis. Statistical signiﬁcance between the individual
groups was analyzed using the unpaired Student’s t test with a
threshold of p , 0.05. Survival of mice was compared using Kaplan-
Meier analysis and log-rank test.
Supporting Information
Accession Numbers
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